Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 30 December 2017 |
| Author/s |
author: James N Ingle Minetta C Liu Tufia C Haddad Matthew P Goetz Vera J Suman |
| Publication date | December 30, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |